Clinical Trial: Open-label, Decentralized Study of SPN-812 (Qelbree®) in Adults With ADHD and Mood Symptoms
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Attention-Deficit/Hyperactivity Disorder
Study Type: INTERVENTIONAL
Official Title: A Phase IV, Open-Label, Decentralized Clinical Trial to Evaluate the Efficacy and Safety of Qelbree® in Adults With Attention-Deficit/Hyperactivity Disorder and Mood Symptoms
Brief Summary:
Open label, flexible dose, decentralized clinical trial evaluating the efficacy and safety of SPN-812 in adults with ADHD and mood symptoms.
Read more